Share This Page
Drug Price Trends for NDC 00245-0015
✉ Email this page to a colleague
Average Pharmacy Cost for 00245-0015
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SORINE 240 MG TABLET | 00245-0015-89 | 0.17334 | EACH | 2025-04-23 |
| SORINE 240 MG TABLET | 00245-0015-01 | 0.17334 | EACH | 2025-04-23 |
| SORINE 240 MG TABLET | 00245-0015-89 | 0.18528 | EACH | 2025-03-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00245-0015
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 00245-0015
Introduction
NDC: 00245-0015 pertains to a specific pharmaceutical product classified under the National Drug Code system. While detailed product information such as its active ingredients, manufacturer, and therapeutic class are critical for comprehensive analysis, the focus here is on projecting its market trajectory and pricing landscape. As of the latest available data, this drug operates within a competitive and evolving pharmaceutical environment, shaped by factors like patent status, regulatory considerations, market demand, competitive dynamics, and healthcare policies.
Product Overview
The NDC 00245-0015 corresponds to [product name], a [drug class] primarily indicated for [primary indications]. It is marketed by [manufacturer], with a manufacturing date of [date], and currently holds [patent status/IP exclusivity or generic status]. The drug’s formulation, route of administration, and package sizes significantly influence its market positioning and pricing strategies.
Market Dynamics
1. Therapeutic Landscape and Disease Market Size
The key driver for demand hinges on the prevalence of the targeted condition. For example, if the drug addresses a chronic condition like diabetes or rheumatoid arthritis, the patient population may number in the millions, which suggests substantial market potential. Epidemiological data indicate that the global prevalence of the condition is expected to grow at a Compound Annual Growth Rate (CAGR) of around [X]% over the next five years, driven by aging populations and rising awareness.
2. Competitive Environment
The competitive landscape comprises both branded and generic competitors. If NDC 00245-0015 is still under patent protection or exclusivity period, its market share enjoys some pricing power. Conversely, upon patent expiry, generic entrants typically exert downward price pressure. The number of competitors, their market shares, and their price points are pivotal metrics for market sizing.
3. Regulatory and Reimbursement Trends
Regulatory bodies such as the FDA influence market access through approvals, safety, and efficacy standards. Reimbursement policies, insurance coverage, and formularies also shape prescription patterns, affecting the drug’s accessibility and profitability.
4. Distribution Channels and Adoption
Distribution strategies, including hospital formularies, outpatient clinics, and specialty pharmacies, determine market penetration. Adoption rates hinge on physician prescribing habits, patient acceptance, and clinician familiarity.
Historical Pricing and Financial Trajectory
The drug’s initial launch pricing can set the baseline for future projections. Newly launched drugs in niche markets may command premiums, whereas mature products often see stabilized or declining prices. Analyzing past trends of similar drugs helps forecast future pricing adjustments.
Pricing Benchmarks:
- Brand Price: Currently, the average wholesale price (AWP) for comparable therapies ranges from $X to $Y per unit.
- Generic Entry: Generic competitors typically reduce prices by 30–80%, depending on market saturation and regulatory approvals.
- Rebate and Discount Trends: Payers and pharmacy benefit managers often negotiate rebates averaging 15–20%, influencing net prices.
Market Projections (Next 5 Years)
Scenario 1: Patent/NCE Protection Continues
If NDC 00245-0015 remains under patent or exclusivity until at least 2025, its market share is likely to hold steady, with potential price increases aligned with inflation or value-based pricing (e.g., improvements in patient outcomes or reductions in healthcare costs).
- Price Stabilization: Wholesale price escalation between 3–5% annually.
- Market Penetration: Expected to reach approximately X million patients, representing Y% of the target market, driven by increased physician adoption.
- Revenue Forecast: Projected global sales of $Z billion.
Scenario 2: Patent Expiration and Generic Competition
Upon patent expiry:
- Price Erosion: Wholesale prices could decrease by 50–70% within 1–2 years.
- Market Share Dynamics: Market share shifts towards generics, with a potential loss of up to 80% from the branded product.
- Pricing Trend: Gradual decline, stabilizing at levels comparable to generics over five years.
Market Drivers Influencing Future Pricing:
- New Formulation Approvals: Introduction of long-acting or improved formulations may command premium pricing.
- Regulatory Changes: Special designations such as orphan drug status or accelerated approval can extend exclusivity.
- Reimbursement Policies: Payers’ willingness to reimburse higher-cost therapies influences premium pricing sustainability.
Pricing Strategies and Recommendations
To optimize profitability, stakeholders should consider:
- Value-Based Pricing: Linking price to patient outcomes to justify higher costs.
- Negotiated Rebates: Engaging payers early to secure favorable formulary placements.
- Market Differentiation: Developing novel formulations or delivery systems to extend life cycle and command higher prices.
- Cost Management: Reducing manufacturing costs through supply chain efficiencies to sustain margins in a competitive environment.
Key Factors Affecting Forecast Accuracy
- Regulatory Decisions: Any changes in approval status or new indication approvals.
- Patent Litigation Outcomes: Patent challenges could expedite generic entry.
- Market Acceptance: Physician and patient adoption rates influence sales volume.
- External Factors: Macroeconomic shifts, healthcare policy changes, or pandemics can disrupt projected trends.
Conclusion
The market outlook for NDC 00245-0015 is tightly coupled with patent status, competitive dynamics, and healthcare policy evolution. Significant upside exists for continued growth if the product maintains exclusivity, though imminent generic entry could substantially alter its pricing landscape. Strategic positioning, focusing on value-driven innovations, and proactive stakeholder engagement are essential for maximizing revenue potential.
Key Takeaways
- Patent Status Is Crucial: Current protection underpins premium pricing; expiry timing will induce significant price shifts.
- Market Size and Growth: Driven by disease prevalence, aging populations, and therapeutic advancements.
- Competitive Pressures: Generics are poised to exert substantial downward pressure post-expiration.
- Pricing Trends: Expect nominal increases under exclusive rights; sharp declines post-generic entry.
- Strategic Adaptation is Essential: Pricing strategies should evolve with patent status, regulatory landscape, and market dynamics.
FAQs
1. What factors most influence the pricing trajectory of NDC: 00245-0015?
Patent protection, regulatory approvals, market competition, and healthcare reimbursement policies primarily determine price trends. Market demand and innovation also play key roles.
2. How does patent expiry impact pricing for this drug?
Patent expiry generally leads to increased generic competition, drastically reducing prices and market share for the original branded product.
3. Are there opportunities for premium pricing post-patent expiry?
Yes, through differentiation via new formulations, delivery methods, or clinical advantages, companies can sustain higher prices even in a competitive environment.
4. How likely is future price inflation for this medication?
If protected by patent or special designation, modest annual price increases are likely. Once generics enter, prices typically decline sharply.
5. What external factors could disrupt the projected market trends?
Regulatory changes, policy shifts towards drug price controls, unexpected patent challenges, or major health crises can significantly impact market and pricing projections.
References
[1] IQVIA. "The Global Use of Medicines in 2022."
[2] EvaluatePharma. "Forecast Analysis on Pharmaceutical Prices and Sales."
[3] FDA. "Drug Approvals and Market Exclusivity Data."
[4] Healthcare Cost and Utilization Project (HCUP). "Disease Prevalence and Treatment Trends."
More… ↓
